A. Osterhaus

发表

Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak

M. Schutten, J. V. van Steenbergen, A. Timen, 2006, Clinical Microbiology and Infection.

J. Peiris, A. Osterhaus, 2005 .

Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies.

J. Sodroski, J. McKeating, J. Goudsmit, 1993, AIDS.

The emerging role of ACE2 in physiology and disease†

R. Korstanje, N. Hooper, M. Cooper, 2007, The Journal of pathology.

Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains.

R. Meloen, J. Langedijk, M. Schutten, 1995, The Journal of general virology.

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant‐DNA hepatitis B vaccine

J. van Hattum, M. Schutten, P. Van Bergen, 2002, Journal of medical virology.

Molecular epidemiology of hepatitis B virus in Amsterdam 1992–1997 *

A. Osterhaus, E. O. D. Op de Coul, H. Niesters, 2002, Journal of medical virology.

Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.

J. Proost, D. Meijer, M. Schutten, 1997, Antiviral research.

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

S. Trottier, O. Carewicz, P. Ward, 2000, The Lancet.

Enhancement of Infectivity of a Non‐Syncytium Inducing HIV‐1 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV‐1

M. Schutten, A. Andeweg, A. Osterhaus, 1995, Scandinavian journal of immunology.

Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro

M. Schutten, C. Baalen, P. Boers, 1998, Journal of Virology.

CD4 T cells remain the major source of HIV-1 during end stage disease.

P. Rácz, M. Schutten, A. Osterhaus, 1999, AIDS.

Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma.

H. Niesters, M. Schutten, B. G. van den Hoogen, 2000, Journal of virological methods.

Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2.

M. Schutten, A. Osterhaus, M. E. van der Ende, 2000, The New England journal of medicine.

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

F Y Aoki, S. Trottier, O. Carewicz, 2000, Lancet.

Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients

A. Osterhaus, B. Maes, B. Bammens, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human bocavirus infection as a cause of severe acute respiratory tract infection in children

M. de Hoog, R. Bodewes, S. Smits, 2015, Clinical Microbiology and Infection.

Measles in a Dutch hospital introduced by an immunocompromised infant from Indonesia infected with a new virus genotype

A. Osterhaus, C. Muller, J. Frenkel, 2000, The Lancet.

Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies.

M. Schutten, A. Osterhaus, R. W. van der Heijden, 1994, AIDS research and human retroviruses.

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism

C. Hack, H. ten Cate, A. Leyte, 2005, Thrombosis journal.

Pharmacokinetics of Succinylated Serum Albumin in Wistar Rats and Cynomolgus Monkeys: Implications for Dosage Regimens in the Therapy of HIV Infection.

J. Proost, D. Meijer, G. van Amerongen, 1996, Drug delivery.

Human antibodies that neutralize primary human immunodeficiency virus type 1 in vitro do not provide protection in an in vivo model.

P. Rácz, M. Schutten, A. Osterhaus, 1996, The Journal of general virology.

Monoclonal antibodies to P2 basic protein and their use in the investigation of some aspects of the Guillain-Barré syndrome

T. Teerlink, A. Osterhaus, S. D. Jong, 1988, Journal of the Neurological Sciences.

Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model.

P. Rácz, M. Schutten, C. Guillon, 2000, The Journal of general virology.

Development of a semi-quantitative real-time RT-PCR for the detection of measles virus.

M. Schutten, R. D. de Swart, M Schutten, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children.

H. Vennema, M. Koopmans, A. Osterhaus, 2009, The Journal of hospital infection.

Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease

A. Osterhaus, P. Cane, S. Chakrabarti, 2003, Bone Marrow Transplantation.

Emerging viruses

A. Osterhaus, W. Lipkin, W Ian Lipkin, 2013, Current Opinion in Virology.

Immunoregulation Mother‐Fetus/Newborn, a RoIe for Anti‐idiotypic Antibodies

A. Osterhaus, L. Hanson, A. Osterhaus, 1989, Acta paediatrica Scandinavica. Supplement.